Gritstone bio (GRTS)
(Delayed Data from NSDQ)
$0.19 USD
-0.01 (-5.00%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $0.19 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Gritstone bio Inc. (GRTS) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$1.25 | $3.00 | $0.50 | 525.00% |
Price Target
Based on short-term price targets offered by four analysts, the average price target for Gritstone bio Inc. comes to $1.25. The forecasts range from a low of $0.50 to a high of $3.00. The average price target represents an increase of 525% from the last closing price of $0.20.
Analyst Price Targets (4 )
Broker Rating
Gritstone bio Inc. currently has an average brokerage recommendation (ABR) of 2.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by six brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on six recommendations.
Of the six recommendations deriving the current ABR, three are Strong Buy, representing 50% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 5 | 6 | 6 | 6 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 3 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
10/1/2024 | JMP Securities | Roy Buchanan | Strong Buy | Hold |
10/1/2024 | H.C. Wainwright & Co. | Sean Lee | Strong Buy | Hold |
10/1/2024 | B. Riley Securities | Mayank Mamtani | Strong Buy | Hold |
10/1/2024 | Evercore Partners | Jonathan Miller | Not Available | Strong Buy |
8/15/2024 | Cowen & Co. | Marc Frahm | Strong Buy | Strong Buy |
8/2/2024 | Piper Sandler | Edward A Tenthoff | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 6 |
Average Target Price | $1.25 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 83 of 252 |
Current Quarter EPS Est: | -0.17 |
GRTS FAQs
Gritstone bio Inc. (GRTS) currently has an average brokerage recommendation (ABR) of 2.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 6 brokerage firms.
The average price target for Gritstone bio Inc. (GRTS) is $1.25. The current on short-term price targets is based on 4 reports.
The forecasts for Gritstone bio Inc. (GRTS) range from a low of $.5 to a high of $3. The average price target represents a increase of $557.89 from the last closing price of $.19.
The current UPSIDE for Gritstone bio Inc. (GRTS) is 557.89%
Based on short-term price targets offered by four analysts, the average price target for Gritstone bio Inc. comes to $1.25. The forecasts range from a low of $0.50 to a high of $3.00. The average price target represents an increase of 525% from the last closing price of $0.20.